Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kresken

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 22, 2008
Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in GermanyM Kresken, E Leitner, J Brauers, et al.
Infection|March 1, 1997
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral doseH Hofbauer, K G Naber, M Kinzig-Schippers, et al.
Journal of Clinical Microbiology|April 28, 2001
Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobialsR R Reinert, C von Eiff, M Kresken, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 29, 2013
[Surveillance of antibiotic consumption : clarification of the "definition of data on the nature and extent of antibiotic consumption in hospitals according to § 23 paragraph 4 sentence 2 of the IfSG"]B Schweickert, W V Kern, K de With, et al.
Der Anaesthesist|December 5, 2018
[S2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults : Focussed summary and supplementary information on antibiotic treatment of critically ill patients]A Brinkmann, A C Röhr, O R Frey, et al.
Infection|January 1, 1994
Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. VM Kresken, D Hafner, H Mittermayer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 2015
Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countriesM Kresken, B Körber-Irrgang, D J Biedenbach, et al.
Medizinische Monatsschrift Fur Pharmazeuten|July 12, 2002
[Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy]Friedrich Vogel, Horst Scholz, B al-Nawas, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 22, 2008
Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in GermanyM Kresken, E Leitner, J Brauers, et al.
Infection|March 1, 1997
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral doseH Hofbauer, K G Naber, M Kinzig-Schippers, et al.
Journal of Clinical Microbiology|April 28, 2001
Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobialsR R Reinert, C von Eiff, M Kresken, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 29, 2013
[Surveillance of antibiotic consumption : clarification of the "definition of data on the nature and extent of antibiotic consumption in hospitals according to § 23 paragraph 4 sentence 2 of the IfSG"]B Schweickert, W V Kern, K de With, et al.
Der Anaesthesist|December 5, 2018
[S2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults : Focussed summary and supplementary information on antibiotic treatment of critically ill patients]A Brinkmann, A C Röhr, O R Frey, et al.
Infection|January 1, 1994
Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. VM Kresken, D Hafner, H Mittermayer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 2015
Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countriesM Kresken, B Körber-Irrgang, D J Biedenbach, et al.
Medizinische Monatsschrift Fur Pharmazeuten|July 12, 2002
[Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy]Friedrich Vogel, Horst Scholz, B al-Nawas, et al.
Pageof 4